Mirae
PrivateLast Round
Seed
Jul 28, 2026
Total Funding Raised
$5.4M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Mirae is a health tech company that provides an AI-driven continuous care platform for managing autoimmune diseases and complex chronic conditions, starting with inflammatory bowel disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement, Vertical SaaS, Healthcare Analytics, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirae Comparables
Compare Mirae with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SonarMD | 76% | |
| Salvo Health | 76% | |
| Orbita | 59% | |
Mirae Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 28, 2026 |
Mirae Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
$5.4M round led by Oxford Science Enterprises
Mirae Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mirae's valuation, stock price, and market status.